It is a pleasure to serve under your chairmanship, Mr Bone. I pay tribute to the hon. Member for Ealing, Southall (Mr Sharma) and congratulate him on calling the debate.
The Government recognise antimicrobial resistance or AMR as a policy issue of huge importance and public interest. It is right and proper that there is scrutiny of the matters we have discussed today. Antimicrobial resistance is one of the greatest public health threats that we face. A landmark study published last year, the Global Research of Antimicrobial Resistance report, reported that more than 1 million human deaths worldwide could be directly attributed to antibiotic resistance in 2019. That was the lower estimate. The report indicated that the figure could be as high as 5 million deaths globally, as the hon. Member for Ealing, Southall indicated in his speech.
Antibiotics are the cornerstone of human medicine. Without them, things we take for granted, such as routine surgery, would become life-threatening. Bacteria cause disease in animals, too, and veterinary medicine, like human medicine, needs to be able to rely on access to antibiotics that work. Not only do animal health and welfare depend on it, so in turn do the food systems that we depend on. It is vital that we protect those medicines for future generations.
To start, I would like to talk about how the Government are tackling antimicrobial resistance and what the UK strategy is. We know that AMR will not be an easy problem to overcome. In 2019, we put in place long-term plans to address AMR and published our UK 20-year vision to contain and control AMR by 2040. That strategic vision is supported by our current five-year
national action plan for AMR, which runs from 2019 to 2024. That plan is progressing well, and I will come shortly to some of its highlights.
Meanwhile, we are already developing the next five-year national action plan. Both the vision and the national action plan were developed across Government Departments and their agencies along with the Administrations in Scotland, Wales and Northern Ireland, supported by a range of stakeholders. Our 20-year vision lays out the UK’s ambitions to create a world where AMR is contained, controlled and mitigated. In it, we have outlined our ambitions for lowering the burden of infections, our plans to optimise the use of antimicrobials across all sectors, and our aims to support the development of new therapies, diagnostics, vaccines and interventions.
We are taking a local, national and global approach. We are tackling AMR in people, animals, food and the environment, which is the One Health approach. The UK’s five-year national action plan takes those ambitions and breaks them down into actions for the UK over the short term. One key ambition of the national action plan is to reduce the use of antibiotics in the UK farming sector.
Let us talk about reducing use in animals. In the UK, the livestock industry is responsible for the health and welfare of more than 1 billion farmed animals in its care each year and for the production of safe, high-quality food. Across the Department for Environment, Food and Rural Affairs, we have been working collaboratively for many years with the veterinary and livestock sectors to promote responsible antibiotic use. UK agriculture has undergone a transformation over the last few years, as livestock sectors have embedded the principles of responsible antimicrobial use in their farming practices. That transformation has led to a clear understanding from all stakeholders of the importance of preserving antimicrobial efficiency and the responsibility that we all have to protect those essential medicines.
Due to the strong working relationship that we have with our vets and farmers, the UK has taken a different approach to other countries in reducing the use of antibiotics in animals, one that has been praised globally. We have engaged with the different sectors and collectively driven a culture change of responsible antibiotic use within food-producing animals. That has led to a 55% decrease in use since 2014, making the UK one of the lowest users of veterinary antibiotics across Europe. In particular, RUMA is establishing and chairing a targets taskforce for vets and farmers. It was pivotal in the industry taking ownership and driving forward that change.
Those industries have worked to protect antibiotics that are important for human use, reducing the use of those critical medicines in animals by 83% since 2014. Of course, the purpose of reducing antibiotic use is to reduce bacterial resistance to antibiotics. At the same time as reducing use, we have been monitoring antibiotic-resistant trends in bacteria in healthy livestock since 2015.